Financhill
Buy
67

DTEGY Quote, Financials, Valuation and Earnings

Last price:
$30.09
Seasonality move :
-0.05%
Day range:
$29.82 - $30.22
52-week range:
$22.03 - $32.47
Dividend yield:
2.72%
P/E ratio:
22.79x
P/S ratio:
0.84x
P/B ratio:
2.29x
Volume:
186.7K
Avg. volume:
272.6K
1-year change:
27.93%
Market cap:
$149.8B
Revenue:
$120.5B
EPS (TTM):
$1.32
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $89.8B $113.8B $127B $119.8B $120.5B
Revenue Growth (YoY) 0.89% 26.8% 11.57% -5.66% 0.58%
 
Cost of Revenues $38.6B $47.5B $55.1B $52.8B $48.2B
Gross Profit $51.1B $66.3B $71.9B $67B $72.3B
Gross Profit Margin 56.96% 58.23% 56.6% 55.95% 60.03%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $476.9M $714.9M $890.9M $1B $692.9M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $40.1B $51.8B $56.2B $52.2B $49.4B
Operating Income $11B $14.5B $15.7B $14.8B $22.9B
 
Net Interest Expenses $2.5B $4.9B $4.7B $4.3B $6.1B
EBT. Incl. Unusual Items $8.1B $9.7B $9B $11.6B $13B
Earnings of Discontinued Ops. -- $167.9M $244.9M $467.2M $14.8B
Income Tax Expense $2.2B $2.1B $2B $2B $4B
Net Income to Company $8.1B $9.9B $9.4B $12.3B $27B
 
Minority Interest in Earnings -$1.6B -$3B -$2.3B -$1.6B -$4.6B
Net Income to Common Excl Extra Items $4.3B $4.7B $4.9B $8.4B $19.3B
 
Basic EPS (Cont. Ops) $0.92 $1.00 $1.03 $1.70 $3.86
Diluted EPS (Cont. Ops) $0.92 $1.00 $1.03 $1.70 $3.86
Weighted Average Basic Share $4.7B $4.7B $4.8B $5B $5B
Weighted Average Diluted Share $4.7B $4.7B $4.8B $5B $5B
 
EBITDA $31.2B $45B $47.5B $46.9B $46.6B
EBIT $11.4B $15.5B $15B $17.6B $20.7B
 
Revenue (Reported) $89.8B $113.8B $127B $119.8B $120.5B
Operating Income (Reported) $11B $14.5B $15.7B $14.8B $22.9B
Operating Income (Adjusted) $11.4B $15.5B $15B $17.6B $20.7B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $30.8B $31.3B $29B $1.2B $1.2B
Revenue Growth (YoY) 38.94% 1.58% -7.34% -95.77% 0.47%
 
Cost of Revenues $12.1B $13.1B $12.4B $11.4B $11.6B
Gross Profit $18.7B $18.2B $16.6B -$10.2B -$10.4B
Gross Profit Margin 60.64% 58.23% 57.14% -830.67% -843.52%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $14.8B $14.3B $13.5B $12.4B $12.7B
Operating Income $3.9B $3.9B $3B -$22.5B -$23.1B
 
Net Interest Expenses $1.1B $1.6B $877.4M $1.5B $1.8B
EBT. Incl. Unusual Items $2.5B $2.2B $2.1B $4.3B $6.3B
Earnings of Discontinued Ops. -- $54.2M $108.8M $3.3M --
Income Tax Expense $578.9M $524.7M $289.1M $1.1B $1.4B
Net Income to Company $2.7B $2.2B $2B $4.3B $6.5B
 
Minority Interest in Earnings -$940.2M -$728.7M -$368.7M -$1.1B -$1.6B
Net Income to Common Excl Extra Items $955.4M $1B $1.6B $2.1B $3.3B
 
Basic EPS (Cont. Ops) $0.20 $0.21 $0.32 $0.42 $0.66
Diluted EPS (Cont. Ops) $0.20 $0.21 $0.32 $0.42 $0.66
Weighted Average Basic Share $4.7B $4.8B $5B $5B $4.9B
Weighted Average Diluted Share $4.7B $4.8B $5B $5B $4.9B
 
EBITDA $12.7B $12B $10.7B $12.4B $14.5B
EBIT $3.9B $3.7B $3.6B $5.9B $8.1B
 
Revenue (Reported) $30.8B $31.3B $29B $1.2B $1.2B
Operating Income (Reported) $3.9B $3.9B $3B -$22.5B -$23.1B
Operating Income (Adjusted) $3.9B $3.7B $3.6B $5.9B $8.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $106B $126.6B $122.4B $90.7B $178B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $43.8B $54.1B $54.6B $48.7B $47.9B
Gross Profit $62.2B $72.5B $67.8B $42B $130.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $49.2B $55.8B $57.2B $49.3B $50.8B
Operating Income $12.9B $16.6B $10.7B -$7.3B $79.3B
 
Net Interest Expenses $4.4B $5.5B $3.1B $6.3B $6.1B
EBT. Incl. Unusual Items $7.4B $11.8B $10.9B $14.2B $16.8B
Earnings of Discontinued Ops. -- $54.2M $281.9M $14.9B $2.2M
Income Tax Expense $2B $2.5B $1.9B $3.5B $4.7B
Net Income to Company $7.7B $11.7B $10.7B $29.1B $16.8B
 
Minority Interest in Earnings -$1.9B -$3.1B -$1.2B -$4.2B -$5.6B
Net Income to Common Excl Extra Items $3.5B $6.4B $8.1B $21.3B $6.5B
 
Basic EPS (Cont. Ops) $0.74 $1.36 $1.66 $4.29 $1.32
Diluted EPS (Cont. Ops) $0.74 $1.36 $1.66 $4.29 $1.32
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $38.9B $51.4B $47.4B $46.8B $50.8B
EBIT $12.2B $18.4B $16.8B $20.9B $24.7B
 
Revenue (Reported) $106B $126.6B $122.4B $90.7B $178B
Operating Income (Reported) $12.9B $16.6B $10.7B -$7.3B $79.3B
Operating Income (Adjusted) $12.2B $18.4B $16.8B $20.9B $24.7B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $82.4B $95B $89.8B $60.4B $61.8B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $32.9B $39.3B $38.8B $34.6B $34.4B
Gross Profit $49.5B $55.6B $51B $25.8B $27.4B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $152.3M $162.7M $177.3M $143.9M $185.7M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $39B $42.9B $38.2B $38.1B $38.6B
Operating Income $10.4B $12.7B $12.8B -$12.3B -$11.1B
 
Net Interest Expenses $3.3B $4B $2.3B $4.3B $4.3B
EBT. Incl. Unusual Items $6.2B $8.3B $9.9B $12.2B $16B
Earnings of Discontinued Ops. -- $54.2M $212.1M $14.7B --
Income Tax Expense $1.6B $2B $1.8B $3.2B $3.9B
Net Income to Company $6.4B $8.3B $9.6B $26.4B $16.1B
 
Minority Interest in Earnings -$1.8B -$1.9B -$754M -$3.4B -$4.4B
Net Income to Common Excl Extra Items $2.8B $4.4B $7.6B $20.3B $7.7B
 
Basic EPS (Cont. Ops) $0.58 $0.94 $1.52 $4.08 $1.55
Diluted EPS (Cont. Ops) $0.58 $0.94 $1.52 $4.08 $1.55
Weighted Average Basic Share $14.2B $14.3B $14.9B $14.9B $14.8B
Weighted Average Diluted Share $14.2B $14.3B $14.9B $14.9B $14.8B
 
EBITDA $31.3B $37.5B $37.1B $36.7B $40.8B
EBIT $10B $12.8B $14.4B $17.3B $21.4B
 
Revenue (Reported) $82.4B $95B $89.8B $60.4B $61.8B
Operating Income (Reported) $10.4B $12.7B $12.8B -$12.3B -$11.1B
Operating Income (Adjusted) $10B $12.8B $14.4B $17.3B $21.4B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $6B $14B $6.8B $6B $8B
Short Term Investments $32.5M $6.1M $6.8M $5.4M $6.6M
Accounts Receivable, Net $12.1B $14.1B $17.3B $18B $17.9B
Inventory $1.8B $3.3B $3.2B $2.8B $2.7B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.3B $1.8B $2B $1.9B $2.4B
Total Current Assets $27.7B $45.9B $43.9B $42B $40.2B
 
Property Plant And Equipment $75.7B $112.3B $89.5B $93.5B $95.1B
Long-Term Investments -- -- -- -- --
Goodwill $13.9B $24.4B $23.2B $22.1B $22.4B
Other Intangibles $62.5B $120.8B $142.2B $141.8B $141B
Other Long-Term Assets $1.1B $1.4B $1.5B $1.6B $1.6B
Total Assets $191.2B $325.8B $318.9B $320.2B $320.9B
 
Accounts Payable $10.5B $11.9B $11.8B $12.8B $11.9B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $4.5B $6.3B $5.7B $5.5B $6.2B
Other Current Liabilities $1.2B $1.2B $2.6B $2.3B $2.6B
Total Current Liabilities $36.9B $45.7B $43.9B $48.7B $39.9B
 
Long-Term Debt $58B $105.8B $102.3B $93.4B $94.5B
Capital Leases -- -- -- -- --
Total Liabilities $139.4B $236.6B $226.6B $226.6B $220B
 
Common Stock $13.7B $15B $14.5B $13.7B $14.1B
Other Common Equity Adj -- -- -- -- --
Common Equity $35.5B $44.2B $48.3B $52.1B $62.9B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $16.3B $45.1B $43.9B $41.6B $37.9B
Total Equity $51.8B $89.2B $92.2B $93.6B $100.9B
 
Total Liabilities and Equity $191.2B $325.8B $318.9B $320.2B $320.9B
Cash and Short Terms $6.1B $14B $6.8B $6B $8B
Total Debt $65.9B $114.9B $113.9B $106.2B $102.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $12.5B $7.4B $8.4B $7.9B $13.6B
Short Term Investments $3.1B $3.8B $4.9B $5.6B $5.4B
Accounts Receivable, Net $15.2B $16.4B $16.8B $16.6B $16B
Inventory $2.7B $2.5B $3.1B $2.7B $2.8B
Prepaid Expenses -- -- -- -- --
Other Current Assets $2.3B $2.2B $1.8B $2.4B $2.6B
Total Current Assets $38.4B $40.1B $41.8B $38.4B $44.8B
 
Property Plant And Equipment $109.6B $105.4B $102.9B $106.6B $105.3B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $1.4B $1.5B $1.6B $1.6B $1.8B
Total Assets $311.5B $317.1B $315.9B $320.2B $322.3B
 
Accounts Payable $9.8B $9.6B $11.3B $10.8B $8.6B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $6B $5.4B $5.4B $6.1B $6.1B
Other Current Liabilities $4.1B $4.6B $4.2B $5.6B $5.8B
Total Current Liabilities $41.2B $40.6B $47.8B $38.6B $38.9B
 
Long-Term Debt $101B $104.2B $91.2B $94.4B --
Capital Leases -- -- -- -- --
Total Liabilities $226.9B $225.6B $223B $218B $219.2B
 
Common Stock $14.3B $14.8B $12.5B $13.5B $14.3B
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $43.6B $43.8B $42.3B $36.5B $37.7B
Total Equity $84.6B $91.5B $92.9B $102.2B $103.2B
 
Total Liabilities and Equity $311.5B $317.1B $315.9B $320.2B $322.3B
Cash and Short Terms $15.6B $11.2B $13.3B $13.6B $19B
Total Debt $108.2B $111.4B $103.4B $100.5B $8.2B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $8.1B $9.9B $9.4B $12.3B $27B
Depreciation & Amoritzation $19.8B $29.5B $32.5B $29.3B $26B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $25.8B $27.1B $38.1B $37.8B $40.4B
 
Capital Expenditures $16.1B $21.3B $31.2B $25.4B $19.3B
Cash Acquisitions -$222.8M -$4.5B -$1.5B $4.4B $8.3B
Cash From Investing -$15.9B -$25.9B -$32.4B -$23.5B -$11.1B
 
Dividends Paid (Ex Special Dividend) -$4B -$3.5B -$3.7B -$3.6B -$4.4B
Special Dividend Paid
Long-Term Debt Issued $7B $39B $15.3B $4.8B $11.9B
Long-Term Debt Repaid -$18.5B -$41.8B -$21.3B -$16.4B -$13.7B
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $11.8B $21.1B $4.7B $4.1B -$15B
Cash From Financing -$8B $8.6B -$12.8B -$16.3B -$27.6B
 
Beginning Cash (CF) $4.1B $6.2B $15.3B $8B $6.2B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.9B $9.8B -$7B -$2B $1.7B
Ending Cash (CF) $6B $14.8B $9B $6.1B $7.9B
 
Levered Free Cash Flow $9.8B $5.8B $6.9B $12.3B $21B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $2.7B $2.2B $2B $4.3B $6.5B
Depreciation & Amoritzation $9.6B $7.9B $6.2B $6.4B $6.7B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $9.2B $10.5B $8.4B $10.5B $12.3B
 
Capital Expenditures $6.1B $5.1B $5.3B $4.6B $6.6B
Cash Acquisitions $951.5M -$1.6B -$132.6M -$11.5M -$10.6M
Cash From Investing -$5.5B -$7.1B -$4.8B -$4.2B -$6.5B
 
Dividends Paid (Ex Special Dividend) -$421.4M -$133.9M $48.6M -$143.3M -$651M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.8B -$10.3B -$1.1M -- --
Long-Term Debt Repaid -$7.6B $13.4B $3.7B -- --
Repurchase of Common Stock -- -- -- -- -$612.1M
Other Financing Activities $1.3B -$6.9B -$3B -$6.5B $1.4B
Cash From Financing -$6.9B -$6.5B -$415.1M -$8B -$1.4B
 
Beginning Cash (CF) $16B $10.7B $5.6B $9.5B $9.3B
Foreign Exchange Rate Adjustment -$713M $151.1M $283.9M $209.2M -$396.8M
Additions / Reductions -$3.2B -$3B $3.1B -$1.6B $4.4B
Ending Cash (CF) $12.4B $7.5B $8.6B $8.1B $13.4B
 
Levered Free Cash Flow $3.1B $5.4B $3.1B $5.9B $5.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $7.7B $11.7B $10.7B $29.1B $16.8B
Depreciation & Amoritzation $27.6B $31.7B $29.7B $27.2B $26.3B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $25.6B $38.1B $35.4B $41.4B $43.1B
 
Capital Expenditures $18.7B $31.4B $24.5B $22B $20.2B
Cash Acquisitions -$4.1B -$1.8B $4.2B $8.5B -$445.3M
Cash From Investing -$22.4B -$34.7B -$21.3B -$14.5B -$20.1B
 
Dividends Paid (Ex Special Dividend) -$3.6B -$3.6B -$3.5B -$4.2B -$6B
Special Dividend Paid
Long-Term Debt Issued $31.2B $8.4B $15.3B -- --
Long-Term Debt Repaid -- -$3.5B -$21.3B -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $21.8B -$2.7B $2.3B -$5.3B -$1.2B
Cash From Financing $2.5B -$8.7B -$12.4B -$27.4B -$17.3B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $5.7B -$5.3B $1.6B -$593.6M $5.6B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $6.9B $6.7B $10.9B $19.4B $22.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $6.4B $8.3B $9.6B $26.4B $16.1B
Depreciation & Amoritzation $22.1B $24.3B $21.5B $19.4B $19.7B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $19.2B $30.2B $27.5B $31.1B $33.8B
 
Capital Expenditures $15.1B $25.1B $18.3B $14.9B $15.8B
Cash Acquisitions -$4.1B -$1.5B $4.2B $8.3B -$402.5M
Cash From Investing -$17.9B -$26.7B -$15.6B -$6.6B -$15.7B
 
Dividends Paid (Ex Special Dividend) -$3.6B -$3.6B -$3.4B -$4B -$5.6B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $30.5B -$0 -- -- --
Long-Term Debt Repaid -$38.3B $0 $0 -- --
Repurchase of Common Stock -- -- -- -- -$1.6B
Other Financing Activities $21.8B -$2.1B -$4.4B -$13.9B -$73.7M
Cash From Financing $5.5B -$11.9B -$11.6B -$22.8B -$12.5B
 
Beginning Cash (CF) $26.5B $38.2B $25.3B $27.4B $28.9B
Foreign Exchange Rate Adjustment -$650.2M $580.1M $620.5M $131.7M -$179.3M
Additions / Reductions $6.8B -$8.4B $267M $1.7B $5.6B
Ending Cash (CF) $33B $30B $25.3B $29.4B $34.4B
 
Levered Free Cash Flow $4.2B $5.1B $9.2B $16.2B $18B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock